These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Public health value of fixed-dose combinations in hypertension. Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530 [TBL] [Abstract][Full Text] [Related]
25. [Economy, costs and drug choices in cardiology. A reflection on the 2012 position paper of the Italian Society of Hypertension]. Camerini F; Palcic S G Ital Cardiol (Rome); 2013 Jun; 14(6):412-5. PubMed ID: 23748537 [No Abstract] [Full Text] [Related]
26. Is more always better? Tuulonen A Acta Ophthalmol Scand; 2004 Aug; 82(4):377-9. PubMed ID: 15291927 [No Abstract] [Full Text] [Related]
27. Variability in antihypertensive drug costs. Chandler M; Hoogland GA N Z Med J; 1989 Sep; 102(875):482. PubMed ID: 2779912 [No Abstract] [Full Text] [Related]
28. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension. Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961 [TBL] [Abstract][Full Text] [Related]
29. [The comparative assessment of the efficacy of hypotensive preparations in stage-II hypertension]. Tiurin VP; Fursov AN; Gospodarenko AL; Liapkova NB; Orlov FA Voen Med Zh; 1997 Nov; 318(11):46-7. PubMed ID: 9461836 [No Abstract] [Full Text] [Related]
30. Angiotensin receptor blockers: impact on costs of care. Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456 [TBL] [Abstract][Full Text] [Related]
32. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis. Fretheim A; Håvelsrud K; MacLennan G; Kristoffersen DT; Oxman AD PLoS Med; 2007 Jul; 4(7):e232. PubMed ID: 17622192 [TBL] [Abstract][Full Text] [Related]
33. Variability in hypertensive drug costs. Kawachi I; Malcolm L; Purdie G N Z Med J; 1989 Sep; 102(876):516-7. PubMed ID: 2797583 [No Abstract] [Full Text] [Related]
34. Trends in antihypertensive medication costs in a cohort of Aucklanders 1982-87. Sinclair BL; Ashton T; Jackson R; Beaglehole R N Z Med J; 1989 Oct; 102(877):521-3. PubMed ID: 2797584 [TBL] [Abstract][Full Text] [Related]
35. [Cost of the treatments of arterial hypertension associated with diabetes]. Passa P; Giraud S Diabete Metab; 1993 Dec; 19(5 Suppl):523-7. PubMed ID: 8206192 [TBL] [Abstract][Full Text] [Related]
36. Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice. Stolk P; Van Wijk BL; Leufkens HG; Heerdink ER J Hum Hypertens; 2006 Dec; 20(12):917-22. PubMed ID: 16988753 [TBL] [Abstract][Full Text] [Related]
37. Economics of hypertension control. Fletcher A J Med Liban; 1994; 42(3):138-44. PubMed ID: 7629847 [No Abstract] [Full Text] [Related]
38. Health economic issues and the future treatment and management of hypertension. Giles TD AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589 [No Abstract] [Full Text] [Related]
39. [Hypertension therapy--never without diuretics?]. Anlauf M MMW Fortschr Med; 2007 Nov; 149(46):31-3. PubMed ID: 18069189 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive drug prescribing in Grampian. Ross S; Macleod MJ Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]